Gene Query: RRP8

Dataset Description Geneva Score
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 16.61
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 12.41
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 12.23
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 10.43
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 10.43
Tracking of dCas9-methyltransferase footprints 10.31
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.06
Genome wide miR-191 target profile determined by RIP and gene expression profiling 9.46
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 9.46
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.31
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 8.97
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.58
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.58
Gene expression analysis of the impact of TDP-43 knockout in human cells. 8.48
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 8.3
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 8.11
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.92
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 7.29
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 7.15
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 6.71
DRB/GRO-Seq -/+ UV 6.67
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.33
NRDE2 negatively regulates nuclear exosome functions 5.94
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.87
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.78
Cleavage Factor Im as a key regulator of 3’ UTR length 5.74
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 5.66
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 5.64
Uridylation by TUT4 and TUT7 marks mRNA for degradation 5.59
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.46
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.46
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 5.34
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.28
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.28
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.27
snRNAs as regulators of alternative splicing 5.22
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.13
MeRIP-seq for heat shock in B-cell lymphoma cells 4.94
Modulation of nonsense-mediated decay by rapamycin 4.91
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 4.6
R430: A potent inbibitor of DNA and RNA viruses 4.56
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 4.43
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.27
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.99
Lysine benzoylation is a novel histone mark 3.92
Lysine benzoylation is a novel histone mark [RNA-seq] 3.92
CROP-Seq in Primary Human T Cells 3.86
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.82
Capturing the Interactome of Newly Transcribed RNA 3.82
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 3.78
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 3.74
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 3.74
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.72
Seletive inhibition of CDK9 in DLBCL cell lines 3.7
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 3.69
The evolution of N6-methyladenosine in primates 3.61
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 3.58
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.58
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.55
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 3.51
Peptidomimetic blockade of MYB in acute myeloid leukemia 3.51
Effect of drugs on transcriptomic profiles 3.46
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 3.45
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 3.44
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 3.42
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 3.42
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.42
UV_24h_GRO-Seq 3.31
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.19
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.19
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.19
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.14
Loss of CREBBP results in gene expression repression in lymphoma cells 3.14
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.08
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.07
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.07
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.05
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.04
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.99
RNA-seq analysis of control and Myc-induced U2OS cells 2.99
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 2.95
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.92
SLAM-seq for K562 endogenous mRNA decay 2.91
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 2.86
RNA-seq of YB5 cells treated with Proscillaridin A 2.75
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.72
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 2.7
RNA-seq of cancer cell lines treated with T-025 2.69
RNA-seq of tumor cells following angiopellosis extravasation 2.69
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 2.64
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.61
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.6
ETV7 and interferon response 2.6
MYC dependent mRNA translation shapes gene expression and cell biology 2.57
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.56
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 2.53
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.49
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.47
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.42
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.42
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.42
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.42
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.4
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.4
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.4
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 2.4
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.39
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.38
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 2.36
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.36
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.35
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 2.33
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.32
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.32
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 2.3
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.28
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.28
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.26
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 2.24
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.22
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.22
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.21
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 2.21
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 2.21
Cajal bodies are linked to genome conformation 2.19
Cajal bodies are linked to genome conformation [RNA-Seq] 2.19
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.19
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.19
Global analysis of enhancer targets: Mosaic-seq 2.18
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 2.18
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.17
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.12
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.12
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 2.11
4sU-seq of HFF exposed to salt and heat stress 2.1
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 2.1
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 2.1
Generating Patterned Kidney Organoids for Studying Development and Diseases 2.04
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 2.04
Identification of renal resident macrophages across species 2.03
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 2.02
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 2.0
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 1.99
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.99
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 1.99
U1 snRNP telescripting regulates size-function stratified human genome 1.98
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.97
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.97
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 1.97
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 1.96
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.95
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.95
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.95
FBXW7 modulates stress response by post-translational modification of HSF1 1.94
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.94
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.94
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.93
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.92
hnRNP C is a key regulator of protein synthesis in mitosis 1.92
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 1.91
Targeted enhancer activation by a subunit of the integrator complex 1.91
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.89
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.88
RNA-seq of naive and primed ES cells 1.86
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.86
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.85
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 1.85
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.85
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.85
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 1.84
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.84
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 1.83
RNAseq Study in CC-671 Treated Cal-51 Cells 1.82
Cell responses to dysregulated VZV-induced cell-cell fusion 1.81
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 1.8
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 1.79
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.79
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 1.77
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.77
Genome-wide discovery of human splicing branchpoints [RNAse] 1.75
Survival of pancreatic cancer cells lacking KRAS function 1.74
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.73
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.73
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 1.72
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 1.72
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.72
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 1.7
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.7
Functional significance of the HIV-1 Tat signature amino acid residues 1.7
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 1.69
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.68
RNA polymerase in pre-B-ALL cell lines 1.68
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.66
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.66
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.66
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.66
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.65
1.65
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 1.65
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 1.64
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.62
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.62
Global gene expression profile of dasatinib-resistant RCH-ACV cells 1.62
The cohesin complex prevents Myc-induced replication stress 1.62
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.61
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 1.6
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 1.59
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 1.58
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.58
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.58
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.55
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.55
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.55
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.55
Accurate annotation of human protein-coding small open reading frames 1.55
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.54
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.51
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 1.51
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.49
Total RNA-seq in ALL-SIL upon JQ1 inhibition 1.48
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.48
CD86 regulates a pro-survival signal in myeloma cells 1.48
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.46
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.46
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.46
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.46
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.45
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.45
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 1.43
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.43
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.42
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.41
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.4
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.4
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.4
MicroRNA-125a-5p overexpression in human macrophages 1.35
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.35
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 1.35
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.34
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.34
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.33
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.33
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.32
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 1.3
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.29
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.29
Downregulation of DDX5/DDX17 and REST 1.28
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.28
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.27
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.27
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.26
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.26
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.26
High-resolution comparative analysis of great ape genomes 1.25
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 1.25
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.24
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.24
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 1.22
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.2
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.2
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.18
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.17
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.17
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 1.17
LIN28A Over-expression RNAseq 1.17
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.16
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 1.15
Real-time observation of light-controlled transcription in living cells 1.14
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.14
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 1.13
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 1.13
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.13
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.12
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.12
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.11
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.11
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.1
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.1
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.1
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.1
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.09
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.09
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.09
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.09
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.08
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.07
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.06
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.05
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 1.05
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.05
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 1.05
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.05
An optimization system for isolating and sequencing of single human colon cancer cells 1.04
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.03
RNA-sequencing in irradiated and normal A549 cells. 1.02
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.01
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.0
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.0
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.0
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.0
Single-cell analysis of adult human ovary using 10X genomics 0.99
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.98
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.98
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.97
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.97
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.95
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.95
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.95
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.93
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.93
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.93
Genome-wide analysis of the Integrator complex 0.93
Genome-wide analysis of the Integrator complex (HTS) 0.93
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.91
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.91
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.91
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.9
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.9
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.87
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.86
A single cell reference map for human blood and tissue T cell activation 0.86
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.85
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.85
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.84
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.84
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.83
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.83
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.83
m6A-dependent regulation of messenger RNA stability 0.83
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.82
p53 activity results in DNA replication fork processivity 0.82
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.82
Recovery and analysis of nascent RNA 0.82
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.81
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.8
Identification of long noncoding RNAs regulated by p53 0.79
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.78
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.77
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.76
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.75
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.75
Illumina Total RNA-seq in HeLa 0.75
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.74
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.73
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.73
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.73
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 0.73
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.73
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 0.72
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.71
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.71
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.71
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.71
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.68
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.67
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.66
K562 polyA RNA-Seq 0.66
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.65
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.65
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.64
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.64
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.63
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.63
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.62
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.61
Oncogenic roles of ARID5B in T-ALL 0.61
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.59
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.58
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.57
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.56
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.56
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.56
SRSF1 role in cellular gene expression and splicing 0.56
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.55
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.55
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.55
Myc activation coordinates gene transcription and protein translation responses 0.54
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.54
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.54
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.54
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.54
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.54
Gene expression profile in breast cancer cells 0.54
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.53
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.52
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 0.51
Determination of tRNA aminoacylation levels by high throughput sequencing 0.51
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.5
Human Treg IFNg/IL-10 subpopulations 0.5
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.49
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.49
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.49
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.49
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.49
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 0.46
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.45
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.45
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.45
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.45
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.42
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.42
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.4
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.4
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.39
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.38
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.38
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.37
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.37
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.37
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.36
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.36
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.36
Discovering human diabetes-risk gene function with genetics and physiological assays 0.35
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.35
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.35
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.34
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.33
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.33
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.33
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.33
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.32
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.32
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.31
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.31
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.3
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.3
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.29
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.28
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.27
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.27
Ribosomal protein RPL26 is the principal target of UFMylation 0.25
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.25
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.25
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.24
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.24
RNA seq with AML (NB4) cells upon FTO inhibition 0.24
The transcriptome and chromatin accessbility landscape of mammalian germline 0.24
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.24
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.24
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.23
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.23
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.23
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.23
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.23
Downregulation of LATS kinases alters p53 to promote cell migration 0.22
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.22
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.22
Interphase condensins regulate ligand-depedent enhancer activation 0.21
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.21
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.19
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.19
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.19
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.19
RNA-Seq from human ILC transitional populations 0.18
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.18
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.17
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.17
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.17
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.17
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.17
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.16
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.15
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.15
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.15
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 0.14
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.14
Transcriptome sequencing of K-562 cells 0.14
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.13
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.13
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.13
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.12
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.11
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.1
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.1
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.09
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.09
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.09
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.06
Identification of global XBP1s target gene expression in human prostate cancer cells 0.04
The pause-initiation limit restricts transcription activation in human cells 0.04
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.04
RNA-seq of resting and activated CD4+ T cells +-JQ1 0.04
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.03
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.02
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.02
Identification of a LIF-responsive replication-competent human β cell 0.02
RNA-seq analysis of differentiating human erythroblasts 0.02
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.02
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.01
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.01
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.01
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.0
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.0
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.0
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation